期刊文献+

促性腺激素释放激素激动剂在女性患者中的临床应用进展 被引量:7

Clinical Application Advances of Gonadotropin-releasing Hormone Agonist in Female Patients
下载PDF
导出
摘要 促性腺激素释放激素激动剂(GnRH-a)是人工合成的GnRH衍生物,通过与垂体的GnRH受体结合可抑制垂体和卵巢功能,从而抑制垂体和卵巢性激素的分泌达降调节作用。目前,GnRH-a在临床中应用较广,对女性患者主要应用于肿瘤性疾病、子宫内膜异位症、不孕症、辅助生育技术中的促排卵、中枢性性早熟以及在化疗前或化疗同时应用以保护患者的卵巢功能。该文就GnRH-a在女性患者中的临床应用进展予以综述。 Gonadotropin-releasing hormone agonist(GnRH agonist,GnRH-A) is a synthetic peptide,it combined pituitary GnRH receptor to inhibit pituitary and ovarian function to reduce the release of the pituitary hormones and ovarian sex hormone.GnRH-As are widely applied in clinical,and fields in women diseases are: tumors,endometriosis,infertility,assisted reproduction,central precocious puberty,ovarian protection before or during chemotherapy.Here is to make a review of the clinical application progress of GnRH-A in female patients.
出处 《医学综述》 2013年第15期2710-2712,共3页 Medical Recapitulate
基金 广西科技厅课题(桂科攻10124001A-43) 广西卫生厅重点课题项目(重2010022)
关键词 促性腺激素释放激素激动剂 女性 临床应用 GnRH-A Female Clinical application
  • 相关文献

参考文献2

二级参考文献3

共引文献7

同被引文献45

  • 1彭萍,杨冬梓,郑澄宇,赖宝玲,罗璐,刘惠芬,何钻玉.促性腺激素释放激素激动剂在化疗患者卵巢功能保护中应用的研究进展[J].中华妇产科杂志,2006,41(2):139-141. 被引量:15
  • 2Minaguchi T, Nakagawa S, Takazawa Y, et al. Combined phospho - Akt and PTEN expressions associated with post - treatment hyster- ectomy after conservative progestin therapy in complex atypical hy- perplasia and stageIa, G1 adenocarcinoma of the endometrium [ J ]. Cancer Lett,2007,248( 1 ) :112.
  • 3连利娟.子宫内膜增生[A].曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2005:2113-2119.
  • 4Mamyama A, Saito T, Hachitanda Y, et al. Cancer history and loss of MSH2 and MLH1 protein expression in patients with endometrial hyperplasis [ J]. IntJ Gynecal Cancer,2003,13 ( 3 ) :352 - 360.
  • 5Rohan TE, Negassa A, Chlebowski RT, et al. Estrogen plus proges- tin and risk of benign proliferative breast disease [ J ]. Cancer Epi- demiol Biomarkers Prev ,2008,17 (9) :2337 - 2343.
  • 6Lee SY, Kim MK, Park H, et al. The effectiveness of levonorer re- leasing intrauterine system in the treatment of endometrial hyperpla- sia in Korean women [ J ]. Gynecol Oncol, 2010,21 ( 2 ) : 102 - 105.
  • 7Ushijima K, Yahata H, Yoshikawa H, et al. Muhicenter phase II study of fertility - sparing treatment with medroxyprogesteron for endometrial carcinoma and atypical hyperplasia in young women [ J]. Clin 0ncol,2007,25:2798 - 2803.
  • 8Sallam HN, Garcia - Velaseo JA, Dias S, et al. Long - term pitui- tary down - regulation before in vitro fertilization(IVF) for women with endometriosis [ J ]. Cochrane Database Syst Rev, 2006,25 (l) :4635.
  • 9李小毛,杨越波,叶敏娟.子宫内膜癌前病变的诊治[J].新医学,2008,39(1):44-46. 被引量:10
  • 10王蔼明,尹善德,李敏,冀立娟,陈蕾.曼月乐治疗子宫内膜非典型增生的临床分析[J].第四军医大学学报,2009,30(16):1498-1500. 被引量:6

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部